New CEO Suman Shirodkar, PhD, to oversee development of diagnostic designed to analyze the epigenetic modification 5hmC in cfDNA
Dako, an Agilent Technologies company specializing in providing cancer diagnostics, said today it has again expanded a three-year-old collaboration with Amgen focused on companion...
Daly will spearhead FIMM's FinnGen biobank genetic project with a goal of collecting genomic information of 500,000 Finns by 2023.
MolecularMD's MRDx BCR-ABL CDx identifies CML patients being treated with Tasigna for initiation and monitoring of treatment-free remission
CAN008 is now under study in a Phase I/II trial in GBM patients in Taiwan, with plans to launch a Phase II trial in glioblastoma in China.
Quest's acquisition creates specialized cancer diagnostics center to provide tumor sequencing, and other genomic and pathology testing.
Immunexpress granted 510(k) clearance for its novel diagnostic in differentiating sepsis from SIRS in critical patients.
Just one night of sleep loss triggers epigenetic, gene expression, and metabolic changes linked to muscle mass loss and an increase in fat
Myriad Genetics said today it will pursue FDA authorization of its BRACAnalysis CDx test as a companion diagnostic for the AstraZeneca/Merck & Co. co-marketed...
Natera’s Signatera test has shown potential in a newly-published survey for guiding treatment decisions after surgery by identifying colorectal cancer recurrence at an average...